By clicking "Allow All" you agree to the storing of cookies on your device to enhance site navigation,
analyse site usage and support us in providing free open access scientific content.
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry.
With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes.
The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies.
In fiscal 2021, the company earned sales revenue of some 3.45 billion euros. At the end of 2021, nearly 14,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
Siemens and Sartorius Stedim Biotech agree on long-term cooperation in the area of automation
Cubis® II Lab Balance: Confident Compliance & Seamless Connectivity
18 common questions about the new European Pharmacopoeia (Ph.Eur.) Chapter 2.1.7
Bringing peak performance from a data sheet to the lab with the Cubis® II
Gravimetric testing and calibration: Performing a norm-compliant process
Measuring uncertainty in a Cubis® II laboratory balance
Medical device quality control and testing: a comprehensive guide
Optimizing lab digitalization through data integrity solutions
Regulating the use of laboratory balances in the pharmaceutical industry
The effect of the EU GMP Annex 1 on air monitoring programs for medical device manufacturers
Smart Cell Monitoring: Resolving the Changing Needs Of Cellular Research with Continuous Live-Cell Analysis